« Back
Home /
Maraviroc

Maraviroc

Item no.	DCC-DC4217-100mg
Manufacturer	DCChemicals
CASRN	376348-65-1
Amount	100 mg
Quantity options	100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category	Cardiovascular Research Atherosclerosis Reagents & Chemicals Molecules
Type	Chemicals
Specific against	other
Purity	>98%
Smiles	FC1(C([H])([H])C([H])([H])C([H])(C([H])([H])C1([H])[H])C(N([H])[C@]([H])(C1C([H])=C([H])C([H])=C([H])C=1[H])C([H])([H])C([H])([H])N1[C@]2([H])C([H])([H])C([H])([H])[C@@]1([H])C([H])([H])C([H])(C2([H])[H])N1C(C([H])([H])[H])=NN=C1C([H])(C([H])([H])[H])C([H])([H])[H])=O)F
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	UK-427857,Celsentri
Similar products	376348-65-1
Available
Manufacturer - Applications	Maraviroc (Selzentry, UK-427857, Celsentri) is a CCR5 antagonist for MIP-1α, MIP-1β and RANTES with IC50 of 3.3 nM, 7.2 nM and 5.2 nM, respectively.
Storage Conditions	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight	513, 6656
Note	For research only, not for human use!
Chemical name	4, 4-difluoro-N-((S)-3-(3-(3-isopropyl-5-methyl-4H-1, 2, 4-triazol-4-yl)-8-aza-bicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 10/9/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer